Abstract
Background. Metaplastic breast carcinomas (MBC) are rare primary breast malignancies characterized by the co-existence of carcinoma with non-epithelial cellular elements. They can be classified as monophasic spindle cell (sarcomatoid) carcinoma, biphasic carcinosarcoma, adenocarcinoma with divergent stromal differentiation (osseous, chondroid and rarely rhabdoid) as well as adenosquamous and pure squamous cell carcinomas. There is a paucity of information on clinically relevant pathologic features and clinical outcomes for these rare tumors. The aim of this study was to review the pathologic features and clinical outcomes of all cases of MBC seen at a single institution between 1971 and 2000.
Methods. A computerized search of the Queen Elizabeth II Health Sciences Center (QEII HSC) surgical pathology files was performed for the years 1971–2000. Tumor blocks from identified cases were reviewed and immunohistochemistry was performed for estrogen and progesterone receptors (ER/PR), HER2/neu protein overexpression and cytokeratin profile. Clinical outcome information was obtained from hospital files and telephone contact with treating physicians.
Results. Twenty-six (26) cases were retrieved with only one case identified before 1990. All tumors were high grade with a median tumor size of 3.7 cm (range 1.4–9.5 cm). Thirteen cases had lymph node dissections available for evaluation, with 4 demonstrating nodal metastases. Five of 26 cases were ER positive within the adenocarcinomatous component, only two of which also expressed PR. Associated ductal carcinoma in situ (DCIS) was present in 11 cases. HER2/neu over-expression was seen in only one (1/26) adenosquamous carcinoma (3 + membranous staining of the malignant glandular component). At 23 months median follow-up, disease free survival (DFS) for the entire group was 53%.
Conclusions. Although a rare breast cancer subtype, MBC is of considerable interest due to its pathological heterogeneity and differences in clinical behavior compared to typical breast carcinomas. Increasing pathologic recognition of MBC as a discrete entity is suggested by the number of MBC diagnoses in the last decade compared to previous years. The poor DFS associated with MBC suggests that further research exploring mechanisms of carcinogenesis and identifying clinically relevant prognostic factors is needed to direct optimum clinical care. Importantly, MBC variants appear to rarely overexpress the HER2/neu oncoprotein.
Similar content being viewed by others
References
FA Tavassoli (1992) ArticleTitleClassification of metaplastic carcinomas of the breast Pathol Annual 27 Pt 2 89–119
PP Rosen (1997) Rosen’s Breast Pathology Lippencott-Raven Philadelphia 375–395
CW Elston IO Ellis (1998) The Breast Churchill Livingstone Edinburg 323–330
ES Wargotz HJ Norris (1989) ArticleTitleMetaplastic carcinomas of the breast: III. Carcinosarcoma Cancer 64 1490–1499 Occurrence Handle1:STN:280:BiaA2snivFc%3D Occurrence Handle2776108
ES Wargotz PH Deos HJ Norris (1989) ArticleTitleMetaplastic carcinomas of breast: II. Spindle cell carcinoma Hum Pathol 20 732–740 Occurrence Handle10.1016/0046-8177(89)90065-8 Occurrence Handle1:STN:280:BiaA3cjisFE%3D Occurrence Handle2473024
H Gutman RE Pollock NA Janjan et al. (1995) ArticleTitleBiological distributions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast J Am Coll Surg 180 193–199 Occurrence Handle1:STN:280:ByqC2M3ovFE%3D Occurrence Handle7850054
CL Carter C Allen DE. Henson (1989) ArticleTitleRelation of tumor size, lymph node status and survival in 24,740 breast cancer cases Cancer 63 181–187 Occurrence Handle1:STN:280:BiaD1cbkvFw%3D Occurrence Handle2910416
JR Harris S. Hellmann (1996) Natural history of breast cancer JR Harris ME Lippmann M Morrow S Hellmann (Eds) Diseases of the Breast Lippencott-Raven PA Philadelphia 375–391
D Rayson AA Adjei VJ Suman et al. (1999) ArticleTitleMetaplastic breast cancer: Prognosis and response to systemic therapy Annals of Oncol 10 413–419 Occurrence Handle1:STN:280:DyaK1M3pvV2hsw%3D%3D
CW Elston IO Ellis (1991) ArticleTitlePathologic prognostic factors in breast cancer The value of histologic grade in breast cancer. Experience from a large study with long term follow-up. Histopathology 19 403–410 Occurrence Handle1:STN:280:By2D1Mfgs1E%3D
HA Oberman (1987) ArticleTitleMetaplastic carcinoma of the breast Am J Surg Path 11 351–358 Occurrence Handle3578645
MP Foschini RE Dina V. Eusebi (1993) ArticleTitleSarcomatoid neoplasms of the breast: proposed definitions for biphasic and monophasic sarcomatoid mammary carcinomas Seminars in Diag Pathol 10 128–136 Occurrence Handle1:STN:280:ByyA2snptlI%3D
ES Wargotz HJ Norris (1990) ArticleTitleMetaplastic carcinomas of the breast: IV. Squamous cell carcinoma of ductal origin Cancer 65 272 Occurrence Handle1:STN:280:By%2BC3cnksV0%3D Occurrence Handle2153044
N. Weidner (1995) ArticleTitleMalignant breast lesions that may mimic benign tumors Seminars in Diagn Pathol 12 2–13 Occurrence Handle1:STN:280:ByqB1cflt1w%3D
C Adem C Reynolds H Adlakha PC Roche AG Nascimento (2002) ArticleTitleWide spectrum screening keratin as a marker of metaplastic spindle cell carcinoma of the breast: an immunohistochemical study of 24 patients Histopathology 40 556–562 Occurrence Handle1:STN:280:DC%2BD38zgs1emuw%3D%3D Occurrence Handle12047767
H Gobbi JF Simpson A Borowsky et al. (1999) ArticleTitleMetaplastic breast tumors with a dominant fibromatosis-like phenotype have a high risk of local recurrence Cancer 85 2170–2182 Occurrence Handle1:STN:280:DyaK1M3ls1KhtQ%3D%3D Occurrence Handle10326695
N Sneige H Yaziji SR Mandavilli et al. (2001) ArticleTitleLow-grade (fibromatosis-like) spindle cell carcinoma of the breast Am J Surg Pathol 25 1009–1016 Occurrence Handle1:STN:280:DC%2BD3MvislShsQ%3D%3D Occurrence Handle11474284
V Eusabi MG Cattan C Ceccarelli et al. (1989) ArticleTitleSarcomatoid carcinoma of the breast: an immunocytochemical study of 14 cases Prog Surg Pathol 10 83–99
MW Kaufman JR Marti HS Gallager JL. Hoehn (1984) ArticleTitleCarcinoma of the breast with pseudosarcomatous metaplasia Cancer 53 1908–1917 Occurrence Handle1:STN:280:BiuC2MnhtlE%3D Occurrence Handle6322962
ES Wargotz HJ Norris (1989) ArticleTitleMetaplastic carcinomas of the breast: I. Matrix-producing carcinoma Hum Pathol 20 628–635 Occurrence Handle1:STN:280:BiaB1M%2FotVU%3D Occurrence Handle2544506
ES Wargotz HJ Norris (1990) ArticleTitleMetaplastic carcinomas of the breast: V. Metaplastic carcinoma with osteoclastic giant cells Hum Pathol 21 1142–1150 Occurrence Handle1:STN:280:By6D3szns1Y%3D Occurrence Handle2227922
JM Park BK Han WK Moon et al. (2000) ArticleTitleMetaplastic carcinoma of the breast: mammographic and sonographic findings J Clin Ultrasound 28 IssueID4 179–186 Occurrence Handle1:STN:280:DC%2BD3c3hs12isQ%3D%3D Occurrence Handle10751739
KM Kurian A Al-Nafussi (2002) ArticleTitleSarcomatoid/metaplastic carcinoma of the breast: a clinicopathological study of 12 cases Histopathology 40 IssueID1 58–64 Occurrence Handle11903598
R Bellino R Arisio F D’Addato (2003) ArticleTitleMetaplastic breast carcinoma: pathology and clinical outcome Anticancer Res 23 669–673 Occurrence Handle12680165
W Hanna FP O’Malley (2002) ArticleTitleUpdated recommendations from the HER2/neu consensus meeting- Toronto, Ontario, September 2001 Current Oncol 9 IssueIDSuppl 1 s18–s20
WC Pitts VA Rojas MJ Gaffey et al. (1991) ArticleTitleCarcinoma with metaplasia and sarcomas of the breast Am J Clin Pathol 95 623–632 Occurrence Handle1:STN:280:By6B387gs1E%3D Occurrence Handle1850949
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barnes, P.J., Boutilier, R., Chiasson, D. et al. Metaplastic breast carcinoma: clinical–pathologic characteristics and HER2/neu expression. Breast Cancer Res Treat 91, 173–178 (2005). https://doi.org/10.1007/s10549-004-7260-y
Issue Date:
DOI: https://doi.org/10.1007/s10549-004-7260-y